🔎 Trials Near Me

Почетна › Карцином на панкреасот › Калифорнија

Клинички испитувања за Карцином на панкреасот во Калифорнија

91 студии за Карцином на панкреасот бараат учесници на локации во Калифорнија.

Градови во Калифорнија

Официјален текст на студијата (англиски)

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Kaiser Permanente-Division of Research, Pleasanton
Се регрутираДобредојдени се здрави волонтери
Возраст од 45 до 75 · Сите полови · Ажурирано 5.10.2026 · NCT06995898

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

  • Research Site, Los Angeles
  • Research Site, San Francisco
Се регрутираФаза 1/2
Возраст од 18 до 130 · Сите полови · Ажурирано 5.10.2026 · NCT05417594

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

  • City of Hope, Duarte
  • University of California San Diego, San Diego
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT07562152

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

  • City of Hope Comprehensive Cancer Center, Duarte
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • City of Hope at Irvine Lennar, Irvine
  • и уште 2
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT05372614

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • City of Hope National Medical Center, Duarte
  • University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
  • UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT06465069

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  • City of Hope - Duarte Cancer Center, Duarte
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT06760819

Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma

  • City of Hope Duarte, Duarte
  • University of California at Los Angeles, Santa Monica
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT07529808

Distance-Based Exercise to Preserve Function and Prevent Disability

  • Kaiser Permanente Dublin, Dublin
  • Kaiser Permanente-Fremont, Fremont
  • Kaiser Permanente Fresno Orchard Plaza, Fresno
  • и уште 10
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT07059884

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • City of Hope, Duarte
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT06172478

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

  • City of Hope National Medical Center, Duarte
  • City of Hope at Irvine Lennar, Irvine
  • Ronald Reagan UCLA Medical Center, Los Angeles
  • и уште 3
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT07090499

A Study of PHN-012 in Patients With Advanced Solid Tumors

  • PHN-012-001 Site, Los Angeles
  • PHN-012-001 Site, San Diego
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 29.9.2026 · NCT07127874

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

  • City of Hope Cancer Center-Duarte, Duarte
  • Providence Medical Foundation, Santa Rosa
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07277413

Pancreatic Cancer Detection Consortium

  • City of Hope Medical Center, Monrovia
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT06388967

DESTINY-PANTUMOUR04

  • Research Site, San Diego
Се регрутираНабљудувачка студија
Возраст од 18 до 130 · Сите полови · Ажурирано 25.9.2026 · NCT07124000

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

  • University of California San Diego, La Jolla
  • Stanford University, Palo Alto
  • UCLA Medical Center, Santa Monica
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT04981119

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

  • UC San Diego Medical Center - Encinitas, Encinitas
  • Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • UCI Health - Irvine, Irvine
  • и уште 14
Се регрутираФаза 2/3
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06989437

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

  • Kivu Trial Site, Santa Monica
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 24.9.2026 · NCT07229313

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

  • UC San Diego Moores Cancer Center, La Jolla
  • Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles
  • University of California, Los Angeles, Los Angeles
  • и уште 3
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 23.9.2026 · NCT07252232

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

  • Investigative Site US051, Duarte
  • Investigative Site US085, Fullerton
  • Investigative Site US054, La Jolla
  • и уште 7
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07522073

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

  • Crosson Cancer Institute at Providence St. Jude Medical Center in Fullerton, Fullerton
  • UCI Health - Irvine, Irvine
  • Cedars-Sinai - Cedars-Sinai Medical Center, Los Angeles
  • и уште 2
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07409272

UCSF PANC Cyst Registry

  • University of California, San Francisco, San Francisco
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT04291651

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

  • UC San Diego Moores Cancer Center, La Jolla
  • Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles
  • UCLA Hematology/Oncology- Santa Monica, Los Angeles
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT06445062

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • UC IRVINE Health, Orange
  • UC Davis Comprehensive Cancer Center, Sacramento
  • Stanford Cancer Institute, Stanford
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT06128551

Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts

  • University of California, San Francisco, San Francisco
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 21.9.2026 · NCT06271291

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

  • Local Institution - 0096, San Francisco
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 16.9.2026 · NCT07492680

CREO - Microwave Ablation Feasibility Study

  • Cedars Sinai, Los Angeles
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 14.9.2026 · NCT07817147

Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study

  • Children's Hospital Los Angeles, Los Angeles
  • Cedars Sinai Medical Center, Los Angeles
  • UCSF Benioff Children's Hospital Oakland, Oakland
  • и уште 1
Се регрутираНабљудувачка студија
До возраст 17 · Сите полови · Ажурирано 11.9.2026 · NCT06651580

Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach

  • City of Hope, Duarte
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 10.9.2026 · NCT05764720

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

  • USC/Norris Comprehensive Cancer Center, Los Angeles
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 9.9.2026 · NCT06440005

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

  • Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank
  • UC San Diego Moores Cancer Center, La Jolla
  • Loma Linda University Medical Center, Loma Linda
  • и уште 5
Се регрутираНабљудувачка студија
Возраст од 50 до 75 · Сите полови · Ажурирано 4.9.2026 · NCT04239573

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

  • University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 4.9.2026 · NCT06400472

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

  • START- Los Angeles, Los Angeles
  • Cedars-Sinai Medical Center, Los Angeles
  • Valkyrie Clinical Trials, Los Angeles
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 3.9.2026 · NCT07644559

Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 3.9.2026 · NCT05687123

PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)

  • Hoag Memorial Hospital Presbyterian, Newport Beach
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 2.9.2026 · NCT06673017

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

  • City of Hope Comprehensive Cancer Center, Duarte
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • City of Hope at Irvine Lennar, Irvine
  • и уште 2
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 1.9.2026 · NCT04172532

Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers

  • Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 31.8.2026 · NCT05497531

Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer

  • Cedars-Sinai, Los Angeles
Се регрутира
Возраст од 18 до 120 · Сите полови · Ажурирано 27.8.2026 · NCT06698458

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

  • University of Southern California, Los Angeles
  • Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
  • Cedars-Sanai Medical Center, Los Angeles
  • и уште 1
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 27.8.2026 · NCT06582017

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

  • Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
  • AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
  • Alta Bates Summit Medical Center-Herrick Campus, Berkeley
  • и уште 20
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 25.8.2026 · NCT06958328

AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer

  • UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 20.8.2026 · NCT07619313

Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.